Response to FDA Commissioner's statement on Dsuvia approval

Michael H Bernstein, Francesca L Beaudoin, Molly Magill, Michael H Bernstein, Francesca L Beaudoin, Molly Magill

No abstract available

Keywords: Dsuvia; Sufentanil; medication; opioid; opioid crisis; prescription opioid.

Conflict of interest statement

Competing Interests: None